youtube_live
Q3 2026 earnings • in 2 days
See detailschevron_right
ISRG:NASDAQ
Intuitive Surgical Inc
$426.70
arrow_downward
-0.27%(-1.16) 1D
Oct 16, 4:00:01 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ISRG...
Open
$428.43
High
$434.89
Low
$425.51
Mkt. cap
150.74B
Avg. vol.
2.23M
Volume
0.00
P/E ratio
48.90
52-wk high
$603.88
52-wk low
$328.57
EPS
$8.73
Beta
1.46
Shares outstanding
353.28M
No. of employees
17K
Open
$428.43
High
$434.89
Low
$425.51
Mkt. cap
150.74B
Avg. vol.
2.23M
Volume
0.00
P/E ratio
48.90
52-wk high
$603.88
52-wk low
$328.57
EPS
$8.73
Beta
1.46
Shares outstanding
353.28M
No. of employees
17K
News stories
From web sources and news partners
Trefis
·
33 minutes ago
How Will Intuitive Surgical Stock React To Its Upcoming Earnings?
ad-hoc-news.de
·
1 hour ago
Intuitive Surgical stock results due October 20 ahead of the Xetra open
TradingView
·
4 hours ago
Intuitive Surgical Earnings: What To Look For From ISRG
ad-hoc-news.de
·
16 hours ago
Intuitive Surgical stock trades at EUR 378.83 in weekend trading
Profile
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.
Intuitive Surgical first appeared on the Fortune 500 in 2024 at number 497; in 2025 the company rose to number 459 overall and ranked 43rd within the healthcare sector. Wikipedia
About Intuitive Surgical Inc
CEODavid J. Rosa
Employees17K
Founded1995
HeadquartersSunnyvale, California, United States
SectorMedical device
Website-
Analyst ratings
Based on 17 analysts giving stock ratings to ISRG in the past 3 months
Strong buy
Buy
15
Hold
2
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for ISRG in the last 3 months.
Highest
Current $426.70
$685.00 (+60.53%)
Average
$489.33 (+14.68%)
Lowest
$391.00 (-8.37%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Anthony Petrone Mizuho Securities | Hold | Reiterated | $415.00 | -2.7% | 10/13/2026 |
Patrick Wood UBS | Buy | Maintained | $500.00 | +17.2% | 10/13/2026 |
Ryan Zimmerman BTIG | Buy | Maintained | $454.00 | +6.4% | 10/12/2026 |
Mike Kratky Leerink Partners | Buy | Reiterated | $473.00 | +10.9% | 10/12/2026 |
Adam Maeder Piper Sandler | Buy | Maintained | $470.00 | +10.1% | 10/07/2026 |
Christopher Pasquale Barclays | Buy | Initiated | $485.00 | +13.7% | 10/07/2026 |
Matt Miksic Barclays | Buy | Maintained | $485.00 | +13.7% | 10/07/2026 |
Joanne Wuensch Citi | Buy | Maintained | $500.00 | +17.2% | 10/05/2026 |
Kendall Au RBC Capital | Buy | Maintained | $575.00 | +34.8% | 10/01/2026 |
Travis Steed Bank of America Securities | Buy | Maintained | $470.00 | +10.1% | 09/21/2026 |
Vik Chopra BMO Capital | Buy | Maintained | - | - | 08/28/2026 |
Lee Hambright Bernstein | Buy | Maintained | $685.00 | +60.5% | 08/11/2026 |
Suraj Kalia Oppenheimer | Buy | Upgraded | $500.00 | +17.2% | 08/12/2026 |
Mathew Blackman TD Cowen | Buy | Maintained | $485.00 | +13.7% | 08/03/2026 |
Helen Fang HSBC | Hold | Downgraded | $391.00 | -8.4% | 07/30/2026 |
Larry Biegelsen Wells Fargo | Buy | Maintained | $487.00 | +14.1% | 07/23/2026 |
Robbie Marcus J.P. Morgan | Buy | Maintained | $450.00 | +5.5% | 07/21/2026 |
Unknown Analyst Mirae Asset | Buy | Upgraded | - | - | 07/21/2026 |
Jayson Bedford Raymond James | Buy | Maintained | $483.00 | +13.2% | 07/17/2026 |
Brandon Vazquez William Blair | Buy | Maintained | - | - | 07/17/2026 |
Shagun Singh Chadha RBC Capital | Buy | Maintained | $575.00 | +34.8% | 07/16/2026 |
David Rescott Robert W. Baird | Buy | Maintained | $500.00 | +17.2% | 07/17/2026 |
Rick Wise Stifel Nicolaus | Buy | Reiterated | $550.00 | +28.9% | 07/17/2026 |
Richard Newitter Truist Financial | Buy | Reiterated | $510.00 | +19.5% | 07/17/2026 |
Unknown Analyst BMO Capital | Buy | Initiated | $518.00 | +21.4% | 07/09/2026 |
Vijay Kumar Evercore ISI | Hold | Maintained | $430.00 | +0.8% | 07/06/2026 |
David Roman Goldman Sachs | Buy | Reiterated | $558.00 | +30.8% | 06/15/2026 |
Imron Zafar Deutsche Bank | Sell | Maintained | $366.00 | -14.2% | 06/02/2026 |
Unknown Analyst Erste Group | Hold | Maintained | - | - | 05/05/2026 |
Unknown Analyst Jefferies | Hold | Reiterated | $515.00 | +20.7% | 04/22/2026 |
Nico Chen DBS | Hold | Maintained | $480.00 | +12.5% | 03/18/2026 |
Danielle Antalffy UBS | Hold | Reiterated | $550.00 | +28.9% | 03/17/2026 |
Next call in 36:56:22
Tue, Oct 20, 10:30 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $2.64
Revenue / Est. (USD)
- / 2.91B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 2.51B | 2.87B | 2.77B | 2.89B |
Cost of goods sold | 842.70M | 961.90M | 940.30M | 931.90M |
Cost of revenue | 842.70M | 961.90M | 940.30M | 931.90M |
Research and development expenses | 329.40M | 352.90M | 361.90M | 370.60M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 573.30M | 687.10M | 613.30M | 617.90M |
Operating expense | 902.70M | 1.04B | 975.20M | 988.50M |
Total operating expenses | 1.75B | 2.00B | 1.92B | 1.92B |
Operating income | 759.70M | 864.30M | 855.30M | 971.90M |
Other non operating income | - | - | - | - |
EBT including unusual items | 855.20M | 955.60M | 940.40M | 1.05B |
EBT excluding unusual items | 855.20M | 950.90M | 939.80M | 1.05B |
Income tax expense | 146.00M | 156.10M | 114.40M | 231.40M |
Effective tax rate | 17.07% | 16.34% | 12.16% | 21.94% |
Other operating expenses | - | - | - | - |
Net income | 704.40M | 794.80M | 821.50M | 818.10M |
Net profit margin | 28.12% | 27.73% | 29.65% | 28.29% |
Earnings per share | 2.40 | 2.53 | 2.50 | 2.80 |
Interest and investment income | 82.30M | 77.50M | 85.70M | 81.10M |
Interest expense | - | - | - | - |
Net interest expenses | 82.30M | 77.50M | 85.70M | 81.10M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 919.70M | 1.02B | 1.06B | 1.20B |
Gain or loss from assets sale | - | 13.70M | -7.90M | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1